nuoK is synthesized in E. coli as a recombinant protein with an N-terminal His-tag to facilitate purification via affinity chromatography. Key production specifications include:
The protein is lyophilized and stored at -20°C/-80°C to maintain stability, with working aliquots kept at 4°C for up to one week .
Complex I is an L-shaped enzyme with a hydrophilic matrix-facing arm and a hydrophobic membrane arm. nuoK belongs to the membrane arm, where it contributes to proton translocation and quinone reduction. The enzyme’s function involves:
NADH oxidation: Catalyzed by the hydrophilic domain.
Electron transfer: Mediated by iron-sulfur clusters.
Proton pumping: Driven by the membrane domain, including nuoK .
nuoK is utilized in diverse studies, including:
Electron transport analysis: Investigating proton-pumping mechanisms in complex I.
Subunit interactions: Mapping interactions between nuoK and other complex I subunits (e.g., nuoL, nuoM) .
ELISA assays: Recombinant nuoK is used in enzyme-linked immunosorbent assays to detect antibodies against B. multivorans in clinical or environmental samples .
Burkholderia pathogenesis: nuoK’s role in energy metabolism may impact bacterial survival in host environments.
| Position | Sequence Segment | Key Features |
|---|---|---|
| 1–20 | MLTLAHYLVLGAILFAIAIVGIFLNRR | Hydrophobic N-terminus; membrane integration |
| 50–70 | GDVHGQ IFVFFVLTVAAAEAAIGLAIL | Conserved motifs for quinone interaction |
| 90–101 | TLFRKLDTINVEDLDQLKG | Proton channel stabilization |
KEGG: bmj:BMULJ_02225
STRING: 395019.BMULJ_02225
The nuoK gene in B. multivorans encodes subunit K of the NADH-quinone oxidoreductase (Complex I), a crucial component of the electron transport chain. This gene is typically located within the nuo operon containing 13-14 genes encoding the various subunits of Complex I. Comparative genomic analysis shows that the nuoK gene is highly conserved among Burkholderia species, including B. cenocepacia, though with some sequence variations that might reflect adaptation to different niches.
When investigating nuoK, researchers should perform comparative sequence analysis using genome sequences available from references like B. multivorans ATCC 17616 and ATCC_BAA-247, as these strains have been used for genome annotation and comparison studies . Multi-locus sequence typing (MLST) can be useful for contextualizing the genetic background of the strain being studied, as B. multivorans shows considerable genetic diversity with at least 64 sequence types identified globally .
Vector selection: pET-based vectors with T7 promoters offer high-level expression, though toxicity can be an issue with membrane proteins like nuoK.
Host strains: C41(DE3) or C43(DE3) E. coli strains are recommended as they are designed for toxic membrane protein expression.
Induction conditions: Lower temperatures (16-18°C) and reduced IPTG concentrations (0.1-0.5 mM) usually result in better folding of membrane proteins.
Fusion tags: A combination of His-tag for purification and fusion partners like MBP or SUMO can improve solubility.
Expression should be validated using Western blotting with antibodies against the fusion tag or nuoK protein itself. Researchers should be aware that successful expression may require optimization based on the specific sequence characteristics of B. multivorans nuoK, as membrane proteins often require strain-specific protocols.
Purification of recombinant nuoK protein presents significant challenges due to its hydrophobic nature as a membrane protein. A methodological approach should include:
Membrane fraction isolation: Differential centrifugation to separate cell membranes following cell lysis.
Solubilization: Careful selection of detergents is critical, with n-dodecyl-β-D-maltoside (DDM) or digitonin being good starting options.
Purification steps:
Immobilized metal affinity chromatography (IMAC) for initial capture
Size exclusion chromatography for removing aggregates and improving purity
Ion exchange chromatography as a polishing step if needed
Researchers should monitor protein quality at each step using SDS-PAGE and Western blotting. Mass spectrometry can confirm protein identity and detect any post-translational modifications. It's worth noting that the oxidative stress encountered by B. multivorans in CF lungs might induce modifications to nuoK , so purification conditions should minimize oxidation by including reducing agents.
Mutations in respiratory chain components like nuoK could significantly impact B. multivorans adaptation during chronic infection. Based on genomic studies of chronic BCC infections, several methodological approaches can address this question:
Longitudinal sequencing: Analyze nuoK sequences from serial isolates collected over the course of chronic infection. The mutation accumulation rate for B. multivorans has been reported as approximately 2.27 SNPs/year in chronic CF infections .
Functional characterization: Engineer isogenic mutants with clinically observed nuoK mutations using site-directed mutagenesis and assess:
Growth rates under aerobic, microaerobic, and anaerobic conditions
Resistance to oxidative stress (relevant to CF lung environment)
Biofilm formation capacity
Antibiotic susceptibility profiles
Transcriptomic analysis: Compare gene expression profiles between wild-type and nuoK mutants to identify compensatory pathways activated when Complex I function is compromised.
Research has shown that B. multivorans undergoes significant adaptive evolution during chronic infection, acquiring mutations in multiple genes related to metabolism and stress response . While specific nuoK mutations weren't directly reported in the available literature, the respiratory chain represents a likely target for adaptation to the low-oxygen CF lung environment.
Transition metal metabolism has emerged as a hotspot for nucleotide polymorphism in chronic BCC infections . nuoK's potential role in this adaptation can be investigated through:
Metal binding analysis: Recombinant nuoK protein can be analyzed for metal binding using techniques such as:
Inductively coupled plasma mass spectrometry (ICP-MS)
Isothermal titration calorimetry (ITC)
X-ray absorption spectroscopy
Growth assays under metal restriction: Compare growth of wild-type and nuoK mutant B. multivorans under conditions of iron, copper, or zinc limitation, which mimic CF lung environments.
Protein-protein interaction studies: Investigate whether nuoK interacts with metal transport proteins using techniques like:
Bacterial two-hybrid assays
Co-immunoprecipitation
Cross-linking mass spectrometry
The research by Nunvar et al. (2017) highlighted that genes related to transition metal metabolism are hotspots for nucleotide polymorphism in chronic BCC infections . Given that respiratory chain complexes often contain iron-sulfur clusters and other metal cofactors, nuoK may be involved in these adaptive processes, potentially affecting electron transport efficiency under the metal-restricted conditions of CF lungs.
The CF lung environment is characterized by high levels of oxidative stress , which could significantly impact nuoK. To investigate this relationship, researchers should consider:
Expression analysis:
qRT-PCR to measure nuoK transcript levels under varying oxidative stress conditions
Western blotting to assess protein levels
Reporter fusions (e.g., nuoK promoter-GFP) to monitor expression in real time
Oxidative damage assessment:
Protein carbonylation assays to measure oxidative damage to nuoK
Mass spectrometry to identify specific oxidation-sensitive residues
Functional assays to determine how oxidation affects NADH dehydrogenase activity
Redox proteomics approach:
Use techniques like OxICAT or redox DIGE to assess the redox state of cysteine residues in nuoK under different oxidative conditions
Research on B. cenocepacia and B. multivorans has revealed that genes associated with oxidative stress response are frequently mutated during chronic infection . A two-component regulatory sensor kinase protein required for sensing and adapting to oxidative stresses was found to be under strong selection pressure in both species, suggesting that respiratory chain components like nuoK might undergo similar adaptation.
To investigate the relationship between nuoK function and B. multivorans virulence, researchers should consider the following methodological approaches:
Genetic manipulation strategies:
Construction of nuoK deletion mutants using allelic exchange
Complementation studies with wild-type and mutant nuoK alleles
CRISPR-Cas9 techniques for precise genome editing
Virulence assays:
Cell culture models using CF bronchial epithelial cells
Galleria mellonella infection model as an intermediate host
Murine models of acute and chronic infection
Functional assessments:
Measurement of intracellular ATP levels as an indicator of energy metabolism
Membrane potential assays to assess proton-motive force generation
Oxygen consumption rate measurements
These approaches should consider that B. multivorans has been associated with poor clinical outcomes in CF patients, including "cepacia syndrome" , and that certain globally distributed strains may be better adapted to human infection than others . The study of nuoK in this context could reveal whether respiratory chain adaptations contribute to this enhanced virulence.
Based on recent studies showing potential parallel pathoadaptation involving antibiotic resistance genes in B. multivorans , investigating nuoK's role requires:
Minimum Inhibitory Concentration (MIC) determination:
Compare MICs of various antibiotics between wild-type and nuoK mutant strains
Assess the effect of sub-inhibitory antibiotic concentrations on nuoK expression
Evaluate synergistic effects of respiratory chain inhibitors with conventional antibiotics
Membrane permeability studies:
Fluorescent dye uptake assays to assess changes in membrane permeability
Lipidomic analysis to detect alterations in membrane composition
Electron microscopy to observe structural changes
Efflux pump activity:
Efflux pump inhibitor assays to determine if nuoK mutations affect drug efflux
Direct measurement of efflux activity using fluorescent substrates
Transcriptomic analysis to identify changes in efflux pump expression
Diaz Caballero et al. (2018) found that B. multivorans can develop resistance to multiple classes of antibiotics during chronic CF infection . Since respiratory chain components affect membrane potential, which drives some efflux pumps, nuoK mutations might contribute to this resistance phenotype through altered energetics or membrane properties.
When facing contradictory data regarding nuoK function, researchers should implement a systematic approach:
Standardization of experimental conditions:
Clearly define growth conditions (media, temperature, oxygen availability)
Ensure consistent genetic backgrounds across studies
Standardize protein expression and purification protocols
Multi-omics integration:
Combine transcriptomic, proteomic, and metabolomic data
Perform flux balance analysis to model energy metabolism
Use 13C-labeling experiments to track metabolic fluxes
Comparative analysis across strains:
The research on B. multivorans shows considerable strain diversity, with some strains better adapted to human infection than others . This genetic diversity likely extends to metabolic capabilities, potentially explaining contradictory findings about respiratory chain components like nuoK across different studies.
Distinguishing adaptive from neutral mutations in nuoK requires sophisticated evolutionary analysis:
Molecular evolution analyses:
Calculate dN/dS ratios to identify signatures of selection
Perform McDonald-Kreitman tests to compare polymorphism and divergence
Use ancestral sequence reconstruction to trace evolutionary trajectories
Experimental evolution approaches:
Conduct in vitro evolution experiments under conditions mimicking CF lungs
Perform competition assays between strains carrying different nuoK alleles
Use allelic replacement to test fitness effects of specific mutations
Clinical correlation studies:
Analyze nuoK sequences from longitudinal clinical isolates
Correlate specific mutations with clinical outcomes
Compare mutation patterns across patients to identify convergent evolution
Studies show that B. multivorans accumulates mutations at a rate of approximately 2.27 SNPs/year during chronic infection , with many mutations affecting genes related to oxidative stress response and metabolism. This evolutionary pattern suggests that adaptive mutations in respiratory chain components like nuoK might contribute to B. multivorans persistence in the CF lung environment.
Based on current knowledge gaps and recent advances, the most promising research directions include:
Structural biology approaches:
Cryo-EM structure determination of the entire B. multivorans Complex I
X-ray crystallography of nuoK in complex with inhibitors
Molecular dynamics simulations to understand conformational changes
Host-pathogen interaction studies:
Investigation of nuoK regulation during different stages of infection
Examination of host immune responses to respiratory chain components
Assessment of nuoK adaptation in response to host environmental pressures
Therapeutic targeting strategies:
Screening for specific inhibitors of B. multivorans nuoK
Evaluation of respiratory chain inhibitors as antibiotic adjuvants
Development of attenuated strains with nuoK modifications as potential vaccine candidates
These approaches should consider that B. multivorans continues to emerge as a significant pathogen in CF infections despite infection control measures , suggesting that understanding its core metabolic processes like electron transport could reveal new therapeutic approaches.